Abstract:ETHNOPHARMACOLOGICAL RELEVANCE: Hepatocellular carcinoma (HCC) as the major histological subtype of primary liver cancer remains one of the most common malignancies worldwide. Due to the complicated molecular pathogenesis of HCC, the option for effective systemic treatment is quite limited. There exists a critical need to explore and evaluate possible alternative strategies for effective control of HCC. With a long history of clinical use, Chinese herbal medicine (CHM) is emerging as a noticeable choice for its multi-level, multi-target and coordinated intervention effects against HCC. With the aids of phytochemistry and molecular biological approaches, in the past decades many CHM-derived compounds have been carefully studied through both preclinical and clinical researches and have shown great potential in novel anti-HCC natural product development. The present review aimed at providing the most recent developments on anti-HCC compounds derived from CHM, especially their underlying pharmacological mechanisms.MATERIALS AND METHODS: A systematic search of anti-HCC compounds from CHM was carried out focusing on literatures published both in English (PubMed, Scopus, Web of Science and Medline) and in Chinese academic databases (Wanfang and CNKI database).RESULTS: In this review, we tried to give a timely and comprehensive update about the anti-HCC effects and targets of several representative CHM-derived compounds, namely curcumin, resveratrol, silibinin, berberine, quercetin, tanshinone II-A and celastrol. Their mechanisms of anti-HCC behaviors, potential side effects or toxicity and future research directions were discussed.CONCLUSION: Herbal compounds derived from CHM are of much significance in devising new drugs and providing unique ideas for the war against HCC. We propose that these breakthrough findings may have important implications for targeted-HCC therapy and modernization of CHM.

Research Progress in Anti-Hepatoma of Active Ingredients in Chinese Materia Medica

Research Progress on Anti-Hepatocellular Carcinoma Mechanism of Active Ingredients of Traditional Chinese Medicine

Research Progress on Anti-Hepatoma Mechanisms of Traditional Chinese Medicine

Research Progress in Anti-tumor Mechanism of Chinese Herbs Extracts

Chinese herbal medicine-derived compounds for cancer therapy: A focus on hepatocellular carcinoma

Research Progress on Pharmacological Activities of Artemisinin and Its Derivatives

Advances in Active Ingredients and Action Mechanism of TCM in Treatment of Hepatic Fibrosis

Polysaccharides from Chinese herbal medicine: a review on the hepatoprotective and molecular mechanism

Antitumor Research of the Active Ingredients from Traditional Chinese Medical Plant Polygonum Cuspidatum

Research progress of anti-tumor active ingredients in Dandelion

[Progress in Studies on Anti-Hepatoma Effect of Traditional Chinese Medicine by Adjusting Immune Function].

Advances in Hepatoprotective Compounds from Medicinal Plants Studies on Natural in China

Current Understanding on Antihepatocarcinoma Effects of Xiao Chai Hu Tang and Its Constituents

Research Progress in Anti-tumor Mechanism of Traditional Chinese Medicine

Anti-cancer natural products isolated from chinese medicinal herbs

Research Progress on the Chemical Constituents and the Anti-Tumor Activity of Angelica Pubescens

Advances in Studies on Antitumor Effective Components of Chinese Herbal Medicines

Research Progress on Active Fractions and Monomers from Natural Drugs in the Treatment of Liver Fibrosis

Main Anti-tumor Angiogenesis Agents Isolated from Chinese Herbal Medicines.

Research Progress on the Anti-Cancer Effects of Astragalus membranaceus Saponins and Their Mechanisms of Action